X0708 D LIVE 0001885827 Virax Biolabs Group Ltd 20 North Audley Street London X0 UNITED KINGDOM W1K 6LX 44 020 7788 7414 CAYMAN ISLANDS None Virax Biolabs (Cayman) Ltd Corporation true 2021 James Alexander Cunliffe Foster 20 North Audley Street London X0 UNITED KINGDOM W1K 6LX Executive Officer Director Mark Ternouth 20 North Audley Street London X0 UNITED KINGDOM W1K 6LX Executive Officer Director Nigel McCracken 20 North Audley Street London X0 UNITED KINGDOM W1K 6LX Executive Officer Evan Norton 20 North Audley Street London X0 UNITED KINGDOM W1K 6LX Director Yair Erez 20 North Audley Street London X0 UNITED KINGDOM W1K 6LX Director Nelson Maurice Haight 20 North Audley Street London X0 UNITED KINGDOM 672 W1K Director Jason Davis 20 North Audley Street London X0 UNITED KINGDOM 672 W1K Executive Officer Biotechnology $1 - $1,000,000 06b false 2023-10-12 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK 2150000 2150000 0 The offering relates to the sale of unregistered warrants to purchase ordinary shares which are exercisable immediately after issuance. The above offering amount does not include the proceeds to be received by the Company upon exercise of such warrants. false 1 150764 0 The placement agent is also entitled to 1.0% management fee ($21,537.68), non-accountable expenses in the amount of $85,000, clearing fee of $15,950, and warrants to purchase up to 513,850 ordinary shares. 2150000 true Issuer expects to use proceeds from the offering for research and development activities and other working capital which includes payment of salaries to executive officers. false Virax Biolabs Group Ltd /s/ Jason Davis Jason Davis Chief Financial Officer 2023-10-17